KITE
-
Novartis Phase III BEOVU data show potential in more diabetic macular edema patients
The Phase III KESTREL and KITE studies enrolled a total of 926 patients in 36 countries Novartis announced positive one-year…
Read More »
The Phase III KESTREL and KITE studies enrolled a total of 926 patients in 36 countries Novartis announced positive one-year…
Read More »